'

News

Stand Ernamín

Ernamín at the 55th Congress of the Spanish Society of Nephrology

From October 16–18, the 55th edition of the Congress of the Spanish Society of Nephrology (SEN) took place in Oviedo For the first time, and following the launch of Ernamín, ERN Laboratories participated as a collaborator in the event, with a stand in the commercial exhibition area and by organizing a technical forum featuring high-level speakers The...

solanes - discurso

Incremental Drug Innovation: A Priority Focus for Laboratorios ERN

David Solanes López, General Manager of Laboratorios ERN, was appointed Academician of the Royal Academy of Pharmacy of Catalonia on October 6, 2025, in the industrial section Solanes dedicated his induction speech to incremental innovation, an area closely linked to his professional career and to Laboratorios ERN’s commitment to developing solutions...

Fosfomicina

FDA has approved intravenous fosfomycin for the treatment of cUTI

On October 22, 2025, the US Food and Drug Administration (FDA) approved intravenous fosfomycin for the treatment of complicated urinary tract infections (cUTI) Laboratorios ERN expresses its satisfaction with the recent approval by the US Food and Drug Administration (FDA) of intravenous fosfomycin for the treatment of patients aged 18 years and older...

Sant Jordi

“A Rose Not to Forget”

Once again, on the occasion of Sant Jordi's Day, April 23rd, 2025, Laboratorios ERN has renewed its commitment to solidarity by joining the Fundació Alzheimer Catalunya As we did in 2024, we wanted to convey a message of support to all people affected by Alzheimer's disease Each rose delivered represents much more than a flower: it is a living symbol of...